In Analyst Interview, Cord Blood America Says Stem Cells Now Front and Center for Researchers and Investors
February 05 2009 - 8:00AM
PR Newswire (US)
SANTA MONICA, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Cord Blood
America, Inc. (OTC:CBAI) (BULLETIN BOARD: CBAI) , the umbilical
cord blood stem cell preservation company
(http://www.cordblood-america.com/ ) focused on bringing the life
saving potential of stem cells to families nationwide and
internationally, said today that Matthew Schissler, founder and
CEO, in an interview with analyst Francis Gaskins, explained that
the Company is very close to becoming cash flow positive. The
complete interview is available at
http://www.stoxrox.com/cbai-feb-b.mp3 . "2009 is a tipping point
year for Cord Blood America. We will continue our organic growth
strategy, adding new health insurance partners and possible new
acquisitions, while continuing to reduce debt," Mr. Schissler said.
Cord Blood America's CEO said he was encouraged that more Federal
spending on stem cell research under President Obama could lead to
more stem cell therapies which, in turn, will lead to more families
storing stem cells. "The stem cell agenda is front and center with
the new Administration," Mr. Schissler said. Cord Blood America's
CEO also referenced the cover story of the new Time magazine, which
cited breakthroughs using stem cells to treat Parkinson's, heart
disease and diabetes. "Investors should understand, in storing
umbilical cord blood stem cells, we have a significant biological
annuity with low bad debt ratio, strong gross profits, and a low
cost structure in place that will allow us to take full advantage
of the expected increase in the storage of stem cells," the
Company's founder said. About Cord Blood America Cord Blood America
(OTC:CBAI) (BULLETIN BOARD: CBAI) is the parent company of CorCell,
which facilitates umbilical cord blood stem cell preservation for
expectant parents and their children. Its mission is to be the most
respected stem cell preservation company in the industry. Collected
through a safe and non-invasive process, cord blood stem cells
offer a powerful and potentially life-saving resource for treating
a growing number of ailments, including cancer, leukemia, blood,
and immune disorders. To find out more about Cord Blood America,
Inc. (OTC:CBAI) (BULLETIN BOARD: CBAI) , visit our website at
http://www.corcell.com/. For investor information, visit
http://www.cordblood-america.com/. CONTACT: Paul Knopick E & E
Communications 949/707-5365 DATASOURCE: Cord Blood America, Inc.
CONTACT: Paul Knopick, E & E Communications, +1-949-707-5365, ,
for Cord Blood America, Inc. Web Site:
http://www.cordblood-america.com/
Copyright